JPWO2024070504A1 - - Google Patents

Info

Publication number
JPWO2024070504A1
JPWO2024070504A1 JP2024513115A JP2024513115A JPWO2024070504A1 JP WO2024070504 A1 JPWO2024070504 A1 JP WO2024070504A1 JP 2024513115 A JP2024513115 A JP 2024513115A JP 2024513115 A JP2024513115 A JP 2024513115A JP WO2024070504 A1 JPWO2024070504 A1 JP WO2024070504A1
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2024513115A
Other languages
Japanese (ja)
Other versions
JPWO2024070504A5 (enExample
JP7586593B2 (ja
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of JPWO2024070504A1 publication Critical patent/JPWO2024070504A1/ja
Publication of JPWO2024070504A5 publication Critical patent/JPWO2024070504A5/ja
Application granted granted Critical
Publication of JP7586593B2 publication Critical patent/JP7586593B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Developmental Biology & Embryology (AREA)
  • Virology (AREA)
  • Zoology (AREA)
  • Physics & Mathematics (AREA)
  • Epidemiology (AREA)
  • Food Science & Technology (AREA)
  • Urology & Nephrology (AREA)
  • General Physics & Mathematics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
JP2024513115A 2022-09-29 2023-09-01 血液保存用組成物及び血液採取容器 Active JP7586593B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2022156247 2022-09-29
JP2022156247 2022-09-29
PCT/JP2023/032121 WO2024070504A1 (ja) 2022-09-29 2023-09-01 血液保存用組成物及び血液採取容器

Publications (3)

Publication Number Publication Date
JPWO2024070504A1 true JPWO2024070504A1 (enExample) 2024-04-04
JPWO2024070504A5 JPWO2024070504A5 (enExample) 2024-09-05
JP7586593B2 JP7586593B2 (ja) 2024-11-19

Family

ID=90477227

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024513115A Active JP7586593B2 (ja) 2022-09-29 2023-09-01 血液保存用組成物及び血液採取容器

Country Status (2)

Country Link
JP (1) JP7586593B2 (enExample)
WO (1) WO2024070504A1 (enExample)

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2014528719A (ja) * 2011-09-26 2014-10-30 プレアナリティクス ゲゼルシャフト ミット ベシュレンクテル ハフツング 細胞外核酸の安定化および単離
JP2016518827A (ja) * 2013-03-18 2016-06-30 キアゲン ゲーエムベーハー 細胞外核酸の安定化および単離
WO2017201612A1 (en) * 2016-05-27 2017-11-30 Norgen Biotek Corp. Preservation of cell-free nucleic acids in biological samples
CN109750087A (zh) * 2019-03-05 2019-05-14 温州广立生物医药科技有限公司 一种血液cfDNA提取试剂盒
WO2020132747A1 (en) * 2018-12-24 2020-07-02 Deltadna Biosciences Inc Composition and method for segregating extracellular dna in blood
CN112359091A (zh) * 2020-10-12 2021-02-12 华南理工大学 一种全血游离dna保存剂、真空采血管及其制备方法
WO2021142375A1 (en) * 2020-01-10 2021-07-15 Sio2 Medical Products, Inc. Nucleic acid and cell preservative compositions and methods of use

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3170079A1 (en) * 2020-03-11 2021-09-16 Kuniya KOMAI Leukocyte concentration separation device, blood collection container, and method for separating leukocytes
JP7169608B1 (ja) * 2022-01-28 2022-11-11 積水メディカル株式会社 血液採取容器、血漿の分離方法、細胞外遊離核酸の分離方法及び細胞外小胞の分離方法
EP4502599A1 (en) * 2022-03-25 2025-02-05 Sekisui Medical Co., Ltd. Kit for isolating circulating tumor cells, container for isolating circulating tumor cells, and method for isolating circulating tumor cells

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2014528719A (ja) * 2011-09-26 2014-10-30 プレアナリティクス ゲゼルシャフト ミット ベシュレンクテル ハフツング 細胞外核酸の安定化および単離
JP2016518827A (ja) * 2013-03-18 2016-06-30 キアゲン ゲーエムベーハー 細胞外核酸の安定化および単離
WO2017201612A1 (en) * 2016-05-27 2017-11-30 Norgen Biotek Corp. Preservation of cell-free nucleic acids in biological samples
WO2020132747A1 (en) * 2018-12-24 2020-07-02 Deltadna Biosciences Inc Composition and method for segregating extracellular dna in blood
CN109750087A (zh) * 2019-03-05 2019-05-14 温州广立生物医药科技有限公司 一种血液cfDNA提取试剂盒
WO2021142375A1 (en) * 2020-01-10 2021-07-15 Sio2 Medical Products, Inc. Nucleic acid and cell preservative compositions and methods of use
CN112359091A (zh) * 2020-10-12 2021-02-12 华南理工大学 一种全血游离dna保存剂、真空采血管及其制备方法

Also Published As

Publication number Publication date
JP7586593B2 (ja) 2024-11-19
WO2024070504A1 (ja) 2024-04-04

Similar Documents

Publication Publication Date Title
BR102022025291A2 (enExample)
JPWO2023181468A1 (enExample)
JPWO2024070504A1 (enExample)
BR102023014872A2 (enExample)
BR102023010976A2 (enExample)
BR102023009641A2 (enExample)
BR102023008688A2 (enExample)
BR102023007252A2 (enExample)
BR102023005164A2 (enExample)
BR102023001987A2 (enExample)
BR102023001877A2 (enExample)
BR102023000289A2 (enExample)
BR102022023461A2 (enExample)
BR102022017795A2 (enExample)
BR202022009269U2 (enExample)
BR202022001779U2 (enExample)
BR202022000931U2 (enExample)
CN307045081S (enExample)
CN307049261S (enExample)
CN307044755S (enExample)
CN307049194S (enExample)
BY13146U (enExample)
CN307049749S (enExample)
CN307050009S (enExample)
CN307044413S (enExample)

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20240226

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20240226

A871 Explanation of circumstances concerning accelerated examination

Free format text: JAPANESE INTERMEDIATE CODE: A871

Effective date: 20240226

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20240402

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20240514

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20240710

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20241008

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20241101

R150 Certificate of patent or registration of utility model

Ref document number: 7586593

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150